Report Detail
Global Biosimilar Drug Market Growth 2019-2024
- RnM2930598 |
- 12 February, 2019 |
- Global |
- 131 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
As healthcare costs continue to rise, biosimilars offer new therapeutic options with the potential for cost savings to the healthcare system. With anticipated savings, biosimilars bring hope that there will be expanded access for patients to not only these known therapies, but also to new innovative medicines. At Amgen, serving patients is at the core of what we do and it is why we’re using our more than 35 years of biologics experience to develop high-quality biosimilars.
First, in pharmerging markets, both governments and patients struggle to pay for biosimilars, which encouraged the demand of biosimilars, therefore in the future the biosimilars will grow around 20%.
Second, generally, biosimilars industry is still in their infancy in China. It is commonly believed that the next 10 to 15 years is the golden period of the development of biosimilars.
Third, for the biosimilars industry, technical barriers will be much smaller, in the next few years, there will be more and more enterprises going into biosimilars industry.
Forth, most of biosimilars manufacturer are concentrated in US, Germany, UK and other developed countries.
At last, through the research we tend to believe that the biosimilars, now is a chance for newcomers and they will greatly change the industry.
According to this study, over the next five years the Biosimilar Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biosimilar Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar Drug market by product type, application, key manufacturers and key regions and countries.
This study considers the Biosimilar Drug value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Injection
Tablets
Other Types
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amgen
Eli Lilly
Novartis
CP Guojian Pharma
Biotech Pharma
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Biosimilar Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Biosimilar Drug market by identifying its various subsegments.
Focuses on the key global Biosimilar Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biosimilar Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Biosimilar Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Biosimilar Drug Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Biosimilar Drug Consumption 2014-2024
- 2.1.2 Biosimilar Drug Consumption CAGR by Region
- 2.2 Biosimilar Drug Segment by Type
- 2.2.1 Injection
- 2.2.2 Tablets
- 2.2.3 Other Types
- 2.3 Biosimilar Drug Consumption by Type
- 2.3.1 Global Biosimilar Drug Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Biosimilar Drug Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Biosimilar Drug Sale Price by Type (2014-2019)
- 2.4 Biosimilar Drug Segment by Application
- 2.4.1 Ankylosing Spondylitis
- 2.4.2 Tumor
- 2.4.3 Rheumatoid Arthrtis
- 2.4.4 Cardiovascular
- 2.4.5 Other Application
- 2.5 Biosimilar Drug Consumption by Application
- 2.5.1 Global Biosimilar Drug Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Biosimilar Drug Value and Market Share by Application (2014-2019)
- 2.5.3 Global Biosimilar Drug Sale Price by Application (2014-2019)
3 Global Biosimilar Drug by Players
- 3.1 Global Biosimilar Drug Sales Market Share by Players
- 3.1.1 Global Biosimilar Drug Sales by Players (2017-2019)
- 3.1.2 Global Biosimilar Drug Sales Market Share by Players (2017-2019)
- 3.2 Global Biosimilar Drug Revenue Market Share by Players
- 3.2.1 Global Biosimilar Drug Revenue by Players (2017-2019)
- 3.2.2 Global Biosimilar Drug Revenue Market Share by Players (2017-2019)
- 3.3 Global Biosimilar Drug Sale Price by Players
- 3.4 Global Biosimilar Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Biosimilar Drug Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Biosimilar Drug Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Biosimilar Drug by Regions
- 4.1 Biosimilar Drug by Regions
- 4.1.1 Global Biosimilar Drug Consumption by Regions
- 4.1.2 Global Biosimilar Drug Value by Regions
- 4.2 Americas Biosimilar Drug Consumption Growth
- 4.3 APAC Biosimilar Drug Consumption Growth
- 4.4 Europe Biosimilar Drug Consumption Growth
- 4.5 Middle East & Africa Biosimilar Drug Consumption Growth
5 Americas
- 5.1 Americas Biosimilar Drug Consumption by Countries
- 5.1.1 Americas Biosimilar Drug Consumption by Countries (2014-2019)
- 5.1.2 Americas Biosimilar Drug Value by Countries (2014-2019)
- 5.2 Americas Biosimilar Drug Consumption by Type
- 5.3 Americas Biosimilar Drug Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Biosimilar Drug Consumption by Countries
- 6.1.1 APAC Biosimilar Drug Consumption by Countries (2014-2019)
- 6.1.2 APAC Biosimilar Drug Value by Countries (2014-2019)
- 6.2 APAC Biosimilar Drug Consumption by Type
- 6.3 APAC Biosimilar Drug Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Biosimilar Drug by Countries
- 7.1.1 Europe Biosimilar Drug Consumption by Countries (2014-2019)
- 7.1.2 Europe Biosimilar Drug Value by Countries (2014-2019)
- 7.2 Europe Biosimilar Drug Consumption by Type
- 7.3 Europe Biosimilar Drug Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Biosimilar Drug by Countries
- 8.1.1 Middle East & Africa Biosimilar Drug Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Biosimilar Drug Value by Countries (2014-2019)
- 8.2 Middle East & Africa Biosimilar Drug Consumption by Type
- 8.3 Middle East & Africa Biosimilar Drug Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Biosimilar Drug Distributors
- 10.3 Biosimilar Drug Customer
11 Global Biosimilar Drug Market Forecast
- 11.1 Global Biosimilar Drug Consumption Forecast (2019-2024)
- 11.2 Global Biosimilar Drug Forecast by Regions
- 11.2.1 Global Biosimilar Drug Forecast by Regions (2019-2024)
- 11.2.2 Global Biosimilar Drug Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Biosimilar Drug Forecast by Type
- 11.8 Global Biosimilar Drug Forecast by Application
12 Key Players Analysis
- 12.1 Amgen
- 12.1.1 Company Details
- 12.1.2 Biosimilar Drug Product Offered
- 12.1.3 Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Amgen News
- 12.2 Eli Lilly
- 12.2.1 Company Details
- 12.2.2 Biosimilar Drug Product Offered
- 12.2.3 Eli Lilly Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Eli Lilly News
- 12.3 Novartis
- 12.3.1 Company Details
- 12.3.2 Biosimilar Drug Product Offered
- 12.3.3 Novartis Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Novartis News
- 12.4 CP Guojian Pharma
- 12.4.1 Company Details
- 12.4.2 Biosimilar Drug Product Offered
- 12.4.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 CP Guojian Pharma News
- 12.5 Biotech Pharma
- 12.5.1 Company Details
- 12.5.2 Biosimilar Drug Product Offered
- 12.5.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Biotech Pharma News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Biosimilar Drug . Industry analysis & Market Report on Biosimilar Drug is a syndicated market report, published as Global Biosimilar Drug Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Biosimilar Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
